A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer

Despite declining smoking rates, lung cancer remains the second most common malignancy in the United States and the leading cause of cancer-related mortality. Non-small cell lung cancer (NSCLC) comprises roughly 85% of cases, and patients tend to present with advanced disease. Historically, concurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Rahul N., Williams, Terence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653152/
https://www.ncbi.nlm.nih.gov/pubmed/33209624
http://dx.doi.org/10.21037/tlcr-20-638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653152/
https://www.ncbi.nlm.nih.gov/pubmed/33209624
http://dx.doi.org/10.21037/tlcr-20-638

Ejemplares similares